Hikma Pharmaceuticals Share News (HIK)

UPDATE: MARKET COMMENT: Stocks Down Ahead Of Weekend Bank Stress Tests

MARKET COMMENT: Stocks Down Ahead Of Weekend Bank Stress Tests

London open: Ebola fears hit UK stocks after NY doctor tests positive for virus

UK stocks experienced some selling pressure on Friday morning after rising to their highest in two weeks, as renewed concerns about the spread of Ebola weighed on market sentiment. The FTSE 100 was down 0.6% at 6,380 in early deals, after having closed Thursday's session at 6,419.15, its highest fin

Hikma Pharmaceuticals receives warning letter from FDA

Pharmaceuticals group Hikma received a warning letter from the US Food and Drug Administration overnight relating to its manufacturing facility in Portugal. The agency raised issues related to investigations and environmental monitoring at the facility. The warning is not expected to impact the manu

UK MORNING BRIEFING: Tesco And BT Lead Fallers In Cautious Market

London pre-open: FTSE to open lower ahead of German data, UK GDP

Reports of a new case of Ebola in the States, together with upcoming EU bank stress test results and German consumer confidence figures, are all set to provide a drag on UK markets at Friday's opening bell. City sources predict the FTSE 100 will open around 20 points lower than Thursday's close of 6

Hikma Pharma says US FDA issues warning on Portugal plant

Oct 24 (Reuters) - Drugmaker Hikma Pharmaceuticals Plc said the U.S. Food and Drug Administration had raised issues related to investigations and environmental monitoring at its plant in Portugal. The Jordanian company said it had received a warning letter from FDA on Thursday following an

Hikma Pharmaceutical Gets FDA Warning Letter On Portugal Facility

Hikma non-exec sells 7,000 shares

Ronald Goode, a non-executive director at Hikma Pharmaceuticals, on Thursday traded in £129,640-worth of shares in the group. The move proved a fortunate one for Goode, as the company's share price fell more than 3% in Friday's trading after the group learned that distribution of its colchicine 0.6

FTSE 250 movers: Telecom Plus climbs as oil stocks slide

Utility services group Telecom Plus said it is happy with market expectations for the full year after strong organic growth in the first half, causing shares to surge on Friday. The company said that the strong growth in both customers and service numbers seen at the start of the year accelerated in

Hikma Pharmaceuticals drug put under restraining order

Distribution of Hikma Pharmaceuticals' food and drug administration (FDA) approved colchicine 0.6mg capsules has been put under a temporary restraining order, the company announced on Friday. The order was granted to Takeda Pharmaceuticals, with litigation between the two companies expected to conti

Hikma To Work For "Positive Outcome" To Takeda Litigation

DIRECTOR DEALINGS: Hikma Non-Executive Director Sells 7,000 Shares

UK BROKER RATINGS: Macquarie Raises LSE, 3I And St James's Place

UK BROKER RATINGS: Merrill Lynch Cuts GKN To Underperform From Buy